• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Hong Kong-Based AI Developer Creates COVID-19 Survival Calculator

Share:

July 29, 2021

AI systems developer Deep Longevity, a unit of Hong Kong-listed Endurance RP Limited, has launched an online tool that can potentially estimate the survival of a hospitalized COVID-19 patients.

WHAT IT DOES

The web-based COVID Risk Calculator provides a patient’s COVID-19 risk score, expected time to death (TTD), and survival probability curve. It requires a physician to input 15 health variables, such as symptoms and comorbidities.

The tool is based on research published last week in the peer-reviewed journal Life. The study collected the blood test results of more than 5,000 COVID-19 positive patients admitted to 11 public hospitals in New York.

It then analyzed those test reports through a deep learning neural network called BloodAge to “quantify the intensity of the aging process” and check a person’s biological age, which can be higher or lower than their chronological age.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

BloodAge predictions can have “more impact on a patient’s survival than chronological age,” based on two survival models: Cox proportional hazards and logistic regression. It was said that each extra BloodAge year is equivalent to a one-day reduction in TTD.

WHY IT MATTERS

In a press statement, Deep Longevity said that risk stratification or assigning risks to admitted patients remains an “essential, albeit grim, necessity” as hospitals around the globe continue to be overwhelmed with new cases.

It noted that age is the main risk factor affecting a COVID-19 patient’s survival. To provide an “accurate” survival analysis, it developed the COVID Risk Calculator to quantify a patient’s aging rate.

Deep Longevity stressed that the calculator has limitations and urged potential users to read its research paper.

THE LARGER TREND

Early in the year, consumer genomics company 23andMe released a similar tool called COVID-19 Severity Calculator which informs users how certain non-genetic factors may impact the risk for hospitalization due to SARS-CoV-2, the virus causing COVID-19. However, it does not predict an individual person’s risk for severe symptoms.

Last year, there were risk assessment tools launched that can tell the probability of a person testing positive for COVID-19. One such tool was developed by Etihad Airways with Vienna-based Medicus AI. Another tool by US-based Cleveland Clinic uses an algorithm to provide a risk score based on a user’s list of symptoms, details of potential exposure to the disease, and demographic data from hospitals. ​​​​

ON THE RECORD

“Age was recognized as the main risk factor affecting patients’ survival at the very onset of the pandemic. The elderly have been reported to have the highest mortality rate, as well as suffer from more complications in numerous studies. In the meantime, most such studies ignore that there is no universal pace of aging. Some people age faster than others. This notion is obvious to medical professionals, who have gained the ability to tell over-agers and under-agers apart throughout the years of practice. However, the official records lack any information on the true, biological age of COVID-19 patients,” Endurance Longevity CEO Jamie Gibson said.

“The research project by Deep Longevity in collaboration with Lincoln Medical Center highlights the importance of quantifying aging rate for accurate survival analysis,” he added.

Source: Mobihealthnews

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Study: Google’s AI Tech Shows Promise in Detecting Breast CancerStudy: Google’s AI Tech Shows Promise in Detecting Breast Cancer
  • Charles River Laboratories Completes the Acquisition of HemaCare CorporationCharles River Laboratories Completes the Acquisition of HemaCare Corporation
  • Waters Corporation Completes Acquisition of Light Scattering Leader Wyatt TechnologyWaters Corporation Completes Acquisition of Light Scattering Leader Wyatt Technology
  • Mayo Clinic Backs Imago Systems to “Re-Visualize” The Mammogram for Breast Cancer Detection – – HIT ConsultantMayo Clinic Backs Imago Systems to “Re-Visualize” The Mammogram for Breast Cancer Detection – – HIT Consultant
  • AZTherapies Strengthens Neuroinflammation-Targeted Pipeline Through Acquisition of Smith TherapeuticsAZTherapies Strengthens Neuroinflammation-Targeted Pipeline Through Acquisition of Smith Therapeutics
  • WoundZoom Digital Wound Management Joins Epic App Orchard MarketplaceWoundZoom Digital Wound Management Joins Epic App Orchard Marketplace
  • Omega 3 Products Market 2019 Global Industry Growth, Size, Demand, Trends, Insights and Forecast 2025Omega 3 Products Market 2019 Global Industry Growth, Size, Demand, Trends, Insights and Forecast 2025
  • Mount Sinai’s New Precision Wellness App Compares The Effectiveness of Wellness-Related TreatmentMount Sinai’s New Precision Wellness App Compares The Effectiveness of Wellness-Related Treatment

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications